- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Equipment
Snapshot for Gen-Probe Inc (GPRO)
| Open: | 81.2800 | Day's Range: | 81.1600 - 81.2800 | Volume: | 379,952 | Bid: | 81.1600 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 81.2000 | 52wk Range: | 53.9200 - 82.5855 | 1-Yr Rtn: | -0.34% | Ask: | 81.1900 |
Key Statistics for GPRO
| Current P/E Ratio (ttm) | 44.8564 |
|---|---|
| Estimated P/E (12/2012) | 31.0241 |
| Earnings Per Share (USD) (ttm) | 1.8100 |
| Est. EPS (USD) (12/2012) | 2.6170 |
| Est. PEG Ratio | 2.3351 |
| Market Cap (M USD) | 3,684.94 |
| Shares Outstanding (M) | 45.39 |
| Enterprise Value (M USD) (ttm) | 3,531.66 |
| Enterprise Value/EBITDA (ttm) | 18.23 |
| Price/Book (mrq) | 4.9338 |
| Price/Sale (ttm) | 6.4328 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More GPRO Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for GPRO
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for GPRO
Gen-Probe Incorporated develops, manufactures, and commercializes diagnostic products based on its genetic probe technologies. The company's products are used for the clinical diagnosis of human diseases and for screening donated human blood. Clinical diagnostic products are marketed to laboratories and public health institutions in the United States and Canada.
| Carl W HullChairman/CEO | Daniel L KacianExec VP/Chief Scientist |
| Herm RosenmanSenior VP:Finance/CFO | Jorgine EllerbrockSenior VP:Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page